The team at @OxfordVacGroup have started a trial to assess children and young adults aged 6-17 with the ChAdOx1 nCoV-19 vaccine - here's an FAQ they've prepared: https://t.co/9KyvaLqzTE
A recent @TMDUniversity paper reveals findings that have potential implications for the early diagnosis of esophageal cancer. Read more: https://t.co/cxqGtkJRK4
Um estudo conduzido pela Faculdade de Medicina da Universidade de São Paulo aponta que a ultrassonografia do pulmão pode ser uma ferramenta para prever o agravamento do quadro de pacientes com Covid-19
https://t.co/eJHIwN22C1
We're very happy to see the ChAdOx1 coronavirus vaccine approved for use in Brazil.
Regulator Anvisa gave the green light to vaccines from Oxford-AstraZeneca and China's Sinovac, doses of which will be distributed among all 27 states.
#oxfordvaccine
https://t.co/GXtfWYoA4V
Our #Covid-19 vaccine knowledge page aims to answer common questions like: How can I get the COVID-19 vaccine? What does safe mean? And many more!
Click the link to find out ⬇️
https://t.co/tsX3uHfiUH
#oxfordvaccine#OxfordVaccineGroup
What to learn more about the COVID-19 vaccines such as vaccine ingredients and safety information?
You find out more on our Vaccine Knowledge Project.
https://t.co/TAPYyroa4H
#COVID19#OxfordVaccineGroup
🔄𝗥𝗲𝘁𝘄𝗲𝗲𝘁 𝘁𝗼 𝘀𝘁𝗼𝗽 𝗺𝗶𝘀𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻🔄